Sensitivity and specificity should never be interpreted in isolation without consideration of other clinical utility metrics.
The purpose of this paper is to highlight the risks and pitfalls of interpreting sensitivity and specificity in isolation when evaluating the clinical utility of a new test/measure to predict a target behavior, disease, or condition. This paper (a) provides a primer for a set of metrics that can be used to appropriately examine the clinical utility of a test/measure (i.e. test operating characteristics - TOC), and (b) provides a discussion regarding various interpretative considerations when using TOCs that supports the tenet of this paper. There are two primary conclusions. First, sensitivity and specificity should never be interpreted in isolation as a means for evaluating the clinical utility of a test/measure. When sensitivity and specificity are used in this manner, more often than not, this will result in erroneous and/or incomplete conclusions regarding the clinical utility of a new test/measure. Second, sensitivity and specificity values are important, but they must be interpreted in conjunction with other more relevant clinical utility metrics (e.g. positive predictive power and negative predictive power).